Immunotherapy before surgery for stage 3 or limited stage 4 melanoma
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether giving two immunotherapy drugs before surgery can help shrink melanoma and improve outcomes. The drugs are given to boost your immune system to attack the cancer before it's removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your melanoma is stage 3 (with visible tumors) or stage 4 with only a few small tumors, and it can be removed with surgery
- You haven't had immunotherapy before
- Your melanoma is not in your internal organs, bones, or brain
- You have adequate kidney, liver, and blood function
- You are willing to use effective contraception if you or your partner can have children
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three immunotherapy drugs (fianlimab, cemiplimab, and ipilimumab) for people with advanced melanoma that has stopped responding to previous PD-1/PD-L1 treatment. It aims to see if this new combination can help shrink or control the cancer.
This trial tests whether giving a combination of three immunotherapy drugs before surgery can help shrink melanoma and improve outcomes. It is for people whose melanoma can be surgically removed, and the goal is to see if this approach is safe and effective.
This trial is for people with stage III melanoma that can be surgically removed. It compares one immunotherapy drug to a combination of two, to see which works better before surgery.
This trial tests whether giving immunotherapy (anti-PD1) before and after surgery can help treat melanoma that has spread to nearby lymph nodes or skin. It is for people whose melanoma can be removed surgically, and who either haven't had systemic treatment before or whose melanoma has returned after prior immunotherapy or targeted therapy.
This trial tests immunotherapy given before surgery to help shrink or control stage III melanoma that has spread to nearby areas (lymph nodes/region). If it works, it may improve outcomes after the melanoma is removed.
This trial tests two immunotherapy drugs, ipilimumab and nivolumab, given before surgery for people whose melanoma has come back after previous anti-PD1 treatment. The goal is to see if this combination can shrink the tumor and help prevent future recurrence.
Hear when a new Melanoma (Skin) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.